DE60140346D1 - System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices - Google Patents

System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices

Info

Publication number
DE60140346D1
DE60140346D1 DE60140346T DE60140346T DE60140346D1 DE 60140346 D1 DE60140346 D1 DE 60140346D1 DE 60140346 T DE60140346 T DE 60140346T DE 60140346 T DE60140346 T DE 60140346T DE 60140346 D1 DE60140346 D1 DE 60140346D1
Authority
DE
Germany
Prior art keywords
qualitative
indices
zellmarker
internal
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140346T
Other languages
English (en)
Inventor
Johannes Gerdes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dako Denmark ApS
Original Assignee
Dako Denmark ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dako Denmark ApS filed Critical Dako Denmark ApS
Application granted granted Critical
Publication of DE60140346D1 publication Critical patent/DE60140346D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Holo Graphy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60140346T 2000-01-24 2001-01-23 System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices Expired - Lifetime DE60140346D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10002803A DE10002803A1 (de) 2000-01-24 2000-01-24 System zur internen qualitativen und quantitativen Validierung von Markerindices
PCT/EP2001/000717 WO2001055346A2 (en) 2000-01-24 2001-01-23 System for the internal qualitative and quantitative validation of marker indices

Publications (1)

Publication Number Publication Date
DE60140346D1 true DE60140346D1 (de) 2009-12-17

Family

ID=7628472

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10002803A Ceased DE10002803A1 (de) 2000-01-24 2000-01-24 System zur internen qualitativen und quantitativen Validierung von Markerindices
DE60140346T Expired - Lifetime DE60140346D1 (de) 2000-01-24 2001-01-23 System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10002803A Ceased DE10002803A1 (de) 2000-01-24 2000-01-24 System zur internen qualitativen und quantitativen Validierung von Markerindices

Country Status (7)

Country Link
US (1) US7560282B2 (de)
EP (1) EP1250599B1 (de)
JP (1) JP5039264B2 (de)
AT (1) ATE447711T1 (de)
DE (2) DE10002803A1 (de)
ES (1) ES2333847T3 (de)
WO (1) WO2001055346A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078098A1 (de) * 1998-05-04 2001-02-28 Dako A/S Verfahren und sonden zur detektion chromosomaler aberrationen
US7648678B2 (en) 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
EP1597578B1 (de) * 2003-02-27 2006-12-20 Dako Denmark A/S Standard für immunhistochemie, immunzytologie und molekulare zytogenetika
GB0304515D0 (en) * 2003-02-27 2003-04-02 Dakocytomation Denmark As Standard
GB0315991D0 (en) * 2003-07-08 2003-08-13 Dakocytomation Denmark As Standard
US20120088233A1 (en) 2010-10-12 2012-04-12 Life Technologies Corporation Method of Preparing Quality Control Material for FFPE
US20170016911A1 (en) * 2014-03-24 2017-01-19 Konica Minolta, Inc. Method for quantifying biological material based on multiple immunostaining
JP6917771B2 (ja) 2017-05-16 2021-08-11 シスメックス株式会社 固定包埋擬似組織及びその利用
JP7025730B2 (ja) * 2018-02-28 2022-02-25 日東紡績株式会社 固定化細胞又はｆｆｐｅ組織切片から抗原性を増強した細胞核を脱離する方法並びにそのための抗原賦活剤及びキット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
EP0260599A3 (de) * 1986-09-12 1990-08-16 DIAGEN Institut für molekularbiologische Diagnostik GmbH Verfahren und Mittel zum Nachweis von Antikörpern gegen menschliche und tierische Retroviren, insbesondere T-lymphotrope Viren
US4816410A (en) * 1986-10-29 1989-03-28 Coulter Corporation Control slide for immunoassay kit and method of making same
JPS63273056A (ja) * 1987-02-06 1988-11-10 ベックマン・リサ−チ・インスティテュ−ト・オブ・ザ・シティ・オブ・ホ−プ マルチ腫瘍組織ブロックならびに同ブロックの製造方法と用途
US5610022A (en) * 1989-09-26 1997-03-11 City Of Hope Internal control for immunocytochemistry assay
JPH05168470A (ja) * 1990-08-08 1993-07-02 W R Grace & Co 複数の細胞種からなる細胞塊状体とシートおよびその製造法
JP3105011B2 (ja) * 1991-02-16 2000-10-30 倭 窪田 培養癌組織
US5478739A (en) * 1992-10-23 1995-12-26 Advanced Tissue Sciences, Inc. Three-dimensional stromal cell and tissue culture system
WO1994023572A1 (en) * 1993-04-08 1994-10-27 Human Cell Cultures, Inc. Cell culturing method and medium
EP0695760A1 (de) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Tumormarker für Lungenkrebs
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
CA2263978A1 (en) * 1996-08-27 1998-03-05 Hemosol Inc. Enhanced stimulation of erythropoiesis
EP0953633A1 (de) * 1998-04-28 1999-11-03 Livercell L.L.C. Zellkulturverfahren und Medium zur Herstellung von vermehrungsfähige, normale, differenzierte Humane Leberzellen
US6281004B1 (en) * 1999-04-14 2001-08-28 Cytologix Corporation Quality control for cytochemical assays

Also Published As

Publication number Publication date
JP5039264B2 (ja) 2012-10-03
WO2001055346A3 (en) 2002-02-14
US7560282B2 (en) 2009-07-14
JP2003520600A (ja) 2003-07-08
ATE447711T1 (de) 2009-11-15
ES2333847T3 (es) 2010-03-02
WO2001055346A2 (en) 2001-08-02
EP1250599B1 (de) 2009-11-04
DE10002803A1 (de) 2001-08-02
US20030124563A1 (en) 2003-07-03
EP1250599A2 (de) 2002-10-23

Similar Documents

Publication Publication Date Title
DE602004017201D1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
EE05465B1 (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
DE60235324D1 (de) Homogene immunoassays für mehrere allergene
WO2005116651A3 (en) Method and device for testing for bence-jones protein
ATE508364T1 (de) Diagnoseverfahren für präeklampsie
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
DE60228557D1 (de) Candida-nachweis
BRPI0516674A (pt) método de análise de mal de alzheimer e reagente de diagnóstico
DE69521608T2 (de) Verwendung von humanem neutrophil-lipocalin(hnl) als diagnostischer marker und anti-hnl-antikörperzubereitung
EP2992332B1 (de) In vitro verfahren zur früherkennung von potenziellen entzündungen, insbesondere im zusammenhang mit der abstossung eines transplantats
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
DE60140346D1 (de) System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices
BR112022007386A2 (pt) Métodos para tratar um câncer hematológico e o uso de biomarcadores companheiros para 2-(2,6-dioxopiperidin-3-il)-4-((2-fluoro-4-((3-morfolinoazetidin-1-il)metil)benzil)amino)isoindolina-1,3-diona
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
NO20050130L (no) Bakteriell testmetode ved glykatert merket binding
BRPI0206904B8 (pt) métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
AU2002233800A1 (en) Method and kit for predicting cancer
DE602004029156D1 (de) Prognose des verlaufs einer krebserkrankung
Pasa et al. Evaluation of serum cystatin-C in dogs with visceral leishmaniasis
EP4368993A3 (de) Gingivitis-diagnoseverfahren, verwendungen und kits
NO20016080L (no) Analyse
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys

Legal Events

Date Code Title Description
8364 No opposition during term of opposition